135 related articles for article (PubMed ID: 35752568)
1. Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study.
Furniss CS; Yurgelun MB; Ukaegbu C; Constantinou PE; Lafferty CC; Talcove-Berko ER; Schwartz AN; Stopfer JE; Underhill-Blazey M; Kenner B; Nelson SH; Okumura S; Law S; Zhou AY; Coffin TB; Rodriguez NJ; Uno H; Ocean AJ; McAllister F; Lowy AM; Lippman SM; Klein AP; Madlensky L; Petersen GM; Garber JE; Goggins MG; Maitra A; Syngal S
Cancer Prev Res (Phila); 2021 Nov; 14(11):1021-1032. PubMed ID: 34625409
[TBL] [Abstract][Full Text] [Related]
2. Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation model.
Pandharipande PV; Heberle C; Dowling EC; Kong CY; Tramontano A; Perzan KE; Brugge W; Hur C
Radiology; 2015 Apr; 275(1):177-87. PubMed ID: 25393849
[TBL] [Abstract][Full Text] [Related]
3. The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants.
Laish I; Schechter M; Dancour A; Lieberman S; Levi Z; Goldberg Y; Kedar I; Hasnis E; Half E; Levi GR; Katz L; Vainer ED; Genzel D; Aharoni M; Chen-Shtoyerman R; Abu-Freha N; Raitses-Gurevich M; Golan T; Bernstein-Molho R; Ben Yehoyada M; Gluck N; Rosner G
Cancer; 2024 Jan; 130(2):256-266. PubMed ID: 37861363
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Risk Factors of Germline Pathogenic Variants in Pancreatic Ductal Adenocarcinoma.
Ryu KH; Park S; Chun JW; Cho E; Choi J; Lee DE; Shim H; Kim YH; Han SS; Park SJ; Woo SM; Kong SY
Cancer Res Treat; 2023 Oct; 55(4):1303-1312. PubMed ID: 37024097
[TBL] [Abstract][Full Text] [Related]
5. Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants.
Murali K; Dwarte TM; Nikfarjam M; Tucker KM; Vaughan RB; Efthymiou M; Collins A; Spigelman AD; Salmon L; Johns AL; Williams DB; Delatycki MB; John T; Stoita A
Hered Cancer Clin Pract; 2021 Aug; 19(1):33. PubMed ID: 34399810
[TBL] [Abstract][Full Text] [Related]
6. Familial Pancreatic Ductal Adenocarcinoma.
Diaz KE; Lucas AL
Am J Pathol; 2019 Jan; 189(1):36-43. PubMed ID: 30558720
[TBL] [Abstract][Full Text] [Related]
7. Evaluating implementation of NCCN guideline-directed genetic screening recommendations for patients with pancreatic ductal adenocarcinoma.
Ghosh AK; Bhushan S; Abidoye O; Robinson SS; Rynarzewska AI; Sampat D
Cancer Causes Control; 2024 Apr; 35(4):679-684. PubMed ID: 38015388
[TBL] [Abstract][Full Text] [Related]
8. A Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study.
Rodriguez NJ; Furniss CS; Yurgelun MB; Ukaegbu C; Constantinou PE; Fortes I; Caruso A; Schwartz AN; Stopfer JE; Underhill-Blazey M; Kenner B; Nelson SH; Okumura S; Zhou AY; Coffin TB; Uno H; Horiguchi M; Ocean AJ; McAllister F; Lowy AM; Klein AP; Madlensky L; Petersen GM; Garber JE; Lippman SM; Goggins MG; Maitra A; Syngal S
Gastroenterology; 2024 May; 166(5):872-885.e2. PubMed ID: 38320723
[TBL] [Abstract][Full Text] [Related]
9. [Pancreatic cancer-screening or surveillance?].
Sirtl S; Vornhülz M; Hofmann FO; Mayerle J; Beyer G
Radiologie (Heidelb); 2023 Dec; 63(12):908-915. PubMed ID: 37878016
[TBL] [Abstract][Full Text] [Related]
10. Understanding the Genetic Landscape of Pancreatic Ductal Adenocarcinoma to Support Personalized Medicine: A Systematic Review.
Pantaleo A; Forte G; Fasano C; Lepore Signorile M; Sanese P; De Marco K; Di Nicola E; Latrofa M; Grossi V; Disciglio V; Simone C
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201484
[TBL] [Abstract][Full Text] [Related]
11. Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in
Astiazaran-Symonds E; Graham C; Kim J; Tucker MA; Ingvar C; Helgadottir H; Pastorino L; van Doorn R; Sampson JN; Zhu B; Bruno W; Queirolo P; Fornarini G; Sciallero S; Carter B; Hicks B; Hutchinson A; Jones K; Stewart DR; Chanock SJ; Freedman ND; Landi MT; Höiom V; Puig S; Gruis N; Yang XR; Ghiorzo P; Goldstein AM
JCO Precis Oncol; 2022 Nov; 6():e2200145. PubMed ID: 36409970
[TBL] [Abstract][Full Text] [Related]
12. Implementing Systematic Genetic Counseling and Multigene Germline Testing for Individuals With Pancreatic Cancer.
Chittenden A; Haraldsdottir S; Ukaegbu C; Underhill-Blazey M; Gaonkar S; Uno H; Brais LK; Perez K; Wolpin BM; Syngal S; Yurgelun MB
JCO Oncol Pract; 2021 Feb; 17(2):e236-e247. PubMed ID: 33439686
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Universal Point-of-Care Genetic Testing in Diverse Patients With Pancreatic Ductal Adenocarcinoma.
Drogan CM; Kindler HL; Gao G; Kupfer SS
JCO Precis Oncol; 2023 Jan; 7():e2200196. PubMed ID: 36689696
[TBL] [Abstract][Full Text] [Related]
14. Expanding access to genetic testing for pancreatic cancer.
Rodriguez NJ; Syngal S
Fam Cancer; 2024 May; ():. PubMed ID: 38733419
[TBL] [Abstract][Full Text] [Related]
15. Risk perception and surveillance uptake in individuals at increased risk for pancreatic ductal adenocarcinoma.
Nguyen D; Gilad O; Drogan CM; Eilers Z; Liao C; Kupfer SS
J Med Genet; 2024 Feb; 61(3):270-275. PubMed ID: 37852748
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness Analysis of Screening for Pancreatic Cancer Among High-Risk Populations.
Peters MLB; Eckel A; Seguin CL; Davidi B; Howard DH; Knudsen AB; Pandharipande PV
JCO Oncol Pract; 2024 Feb; 20(2):278-290. PubMed ID: 38086003
[TBL] [Abstract][Full Text] [Related]
17. Genetic testing to guide screening for pancreatic ductal adenocarcinoma: Results of a microsimulation model.
Peters MLB; Eckel A; Lietz A; Seguin C; Mueller P; Hur C; Pandharipande PV
Pancreatology; 2022 Sep; 22(6):760-769. PubMed ID: 35752568
[TBL] [Abstract][Full Text] [Related]
18. Screening for Pancreatic Adenocarcinoma in BRCA2 Mutation Carriers: Results of a Disease Simulation Model.
Pandharipande PV; Jeon A; Heberle CR; Dowling EC; Kong CY; Chung DC; Brugge WR; Hur C
EBioMedicine; 2015 Dec; 2(12):1980-6. PubMed ID: 26844277
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
